⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7158375 | 1.00 | — | — | |
| Potassium Ion SCHEMBL23462122 | 0.00 | CA4 (0.50) | — | |
| Potassium Ion SCHEMBL23462037 | 0.00 | CA4 (0.50) | — | |
| SCHEMBL23668207 | 0.00 | — | — | |
| SCHEMBL23461961 | 0.00 | — | — | |
| Potassium Ion SCHEMBL23462189 | 0.00 | CA4 (0.50) | — | |
| Water SCHEMBL25436674 | 0.00 | — | — | |
| SCHEMBL25239884 | 0.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL25435623 | 0.00 | — | — | |
| SCHEMBL25437025 | 0.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3721233-A2 | METHODS FOR AIDING IN THE DIAGNOSIS AND EVALUATION OF A SUBJECT WHO HAS SUSTAINED AN ORTHOPEDIC INJURY AND THAT HAS OR MAY HAVE SUSTAINED AN INJURY TO THE HEAD, SUCH AS MILD TRAUMATIC BRAIN INJURY (TBI), USING GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) AND/OR UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCH-L1) | Abbott Laboratories (US) | 2020-10-14 | — | — | EP | disclosed |
| EP-3516421-A2 | LIDAR SYSTEMS AND METHODS | Innoviz Technologies Ltd. (IL) | 2019-07-31 | — | — | EP | disclosed |
| WO-2019113525-A2 | METHODS FOR AIDING IN THE DIAGNOSIS AND EVALUATION OF A SUBJECT WHO HAS SUSTAINED AN ORTHOPEDIC INJURY AND THAT HAS OR MAY HAVE SUSTAINED AN INJURY TO THE HEAD, SUCH AS MILD TRAUMATIC BRAIN INJURY (TBI), USING GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) AND/OR UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCH-L1) | ABBOTT LABORATORIES (US) | 2019-06-13 | — | — | WO | disclosed |